The features of the pathologic changes in chronic oxalate stone disease after 16 week of experimental phase


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Acesso é pago ou somente para assinantes

Resumo

Aim. to study the pathologic features of chronic oxalate stone disease. Materials and methods. a model of the experimental oxalate stone disease was done in rats that drank the 1% ethylene glycol solution for 16 weeks. The pathologic analysis of the rats’ kidneys was done. Results. After 16 weeks of oxalate stone disease modeling in all parts of kidneys the large crystals deposits were found, which plugged renal tubules. Moreover, purulent calculous pyelonephritis developed complicated by fibrosis.

Texto integral

Acesso é fechado

Sobre autores

G. Zharikova

FGBOU VO «Altai State Medical University» of the Ministry of Health of Russia

Email: ganna1704@mail.ru
Lecturer at the Department ofGeneral and Biological Chemistry, clinical diagnostic laboratory

V. Bryukhanov

FGBOU VO «Altai State Medical University» of the Ministry of Health of Russia

Email: bvm@agmu.ru
Dr.Med.Sci, professor at the Department of Pharmacology

A. Neymark

FGBOU VO «Altai State Medical University» of the Ministry of Health of Russia

Email: urologagmu@mail.ru
Dr.Med.Sci, professor, Department of Specialized Surgery

A. Zharikov

FGBOU VO «Altai State Medical University» of the Ministry of Health of Russia

Email: zharikov_a_y@mail.ru
Dr.Bio.Sci., associate professor, Head of the Department of Pharmacology

I. Bobrov

FGBOU VO «Altai State Medical University» of the Ministry of Health of Russia

Email: ig.bobrov2010@yandex.ru
Dr.Med.Sci, head of the pathological laboratory of the Center of Medical and Biologic Studies

N. Yakushev

FGBOU VO «Altai State Medical University» of the Ministry of Health of Russia

Email: yakushevnn@mail.ru
Cand.Med.Sci., associate professor at the Department of Pharmacology

Bibliografia

  1. Han H., Segal A.M., Seifter J.L., Dwyer J.T. Nutritional Management of Kidney Stones (Nephrolithiasis). Clin Nutr Res. 2015;4(3):137-152.
  2. Ziemba J.B., Matlaga B.R. Epidemiology and economics of nephrolithiasis. Investig Clin Urol. 2017;58(5):299-306.
  3. Брюханов В.М., Зверев Я.Ф., Лампатов В.В., Жариков А.Ю., Азарова О. В., Мотин Ю.Г. Функция почек в условиях экспериментального оксалатного нефролитиаза Нефрология. 2008;12(1):69-74
  4. Жариков А.Ю., Зверев Я.Ф., Лампатов В.В., Брюханов В.М., Азарова О.В., Талалаева О.С., Мотин Ю.Г. Применение викасола как перспективного средства фармакологической коррекции экспериментального нефролитиаза. Бюллетень сибирской медицины. 2012;11(1):18-24
  5. Мотин Ю.Г., Лапий Г.А., Лепилов А.В., Бгатова Н.П., Жариков А.Ю., Мотина Н.В., Непомнящих Л.М. Морфологическое исследование почек крыс при экспериментальном оксалатном нефролитиазе. Фундаментальные исследования. 2015;1-8:1639-1644
  6. Scales C.D. Jr, Tasian G.E., Schwaderer A.L., Goldfarb D.S., Star R.A., Kirkali Z. Urinary Stone Disease: Advancing Knowledge, Patient Care, and Population Health. Clin J Am Soc Nephrol. 2016;11(7):1305-1312
  7. Жариков А.Ю., Брюханов В.М., Зверев Я.Ф., Лампатов В.В. Современные методы моделирования оксалатного нефролитиаза. Нефрология. 2008;12(4):28-35
  8. Khan S.R., Pearle M.S., Robertson W.G., Gambaro G., Canales B.K., Doizi S., Traxer O., Tiselius H.G. Kidney stones. Nat Rev Dis Primers. 2016;25;2:16008. doi: 10.1038/nrdp.2016.8.
  9. O’Kell A.L., Grant D.C., Khan S.R. Pathogenesis of calcium oxalate urinary stone disease: species comparison of humans, dogs, and cats. Urolithiasis. 2017;45(4):329-336.

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML

Declaração de direitos autorais © Bionika Media, 2018

Este site utiliza cookies

Ao continuar usando nosso site, você concorda com o procedimento de cookies que mantêm o site funcionando normalmente.

Informação sobre cookies